Company Filing History:
Years Active: 1990-2005
Title: The Innovations of Harald Von Keyserlingk
Introduction
Harald Von Keyserlingk is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases. With a total of 4 patents to his name, his work continues to impact the medical community.
Latest Patents
One of his latest patents focuses on the "Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases." This invention relates to the use of esters of estriol, such as estriol 3,17-dipropionate or estriol 3,17-dihexanoate, for treating conditions like multiple sclerosis (MS). Another significant patent involves "Halogenated olefins, processes for their preparation and their use as." This patent describes new halogenated olefins of a specific general formula, along with processes for their preparation. These compounds can be utilized as pesticides, particularly against insects and acarids.
Career Highlights
Harald Von Keyserlingk has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has allowed him to develop innovative solutions that address critical health issues.
Collaborations
He has collaborated with notable colleagues such as Hartmut Joppien and Arnim Kohn, contributing to a dynamic research environment that fosters innovation.
Conclusion
Harald Von Keyserlingk's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of autoimmune diseases and agricultural applications.